"We recently approached ImmunoGenes and they were able to deliver monoclonal antibodies specific to CB-1, which upon characterization yielded the first monoclonal antibody displaying formidable characteristics and fulfilling our extensive expectations. This antibody displays superior specificity and binding characteristics, making it an irreplaceable tool in our CB-1 development programs." -

Enter the ImmunoGenes contest and win a monoclonal antibody development project against a difficult target at a special price.

Our patented technology allows us to produce high quality and diverse antibodies against extremely challenging antigens.

ImmunoGenes is the leader in developing transgenic concepts based on published research by experienced scientists.